Glucocorticoid-induced diabetes among people without diabetes: a literature review

Majid Alabbood, Min Ling, Kenneth Ho

Research output: Contribution to journalReview articleResearchpeer-review

Abstract

The effect of glucocorticoid on glycaemic control in people with diabetes has been studied extensively in the literature. However, data regarding its effect on glucose homeostasis in those without diabetes are sparse. This review aims to investigate the incidence of glucocorticoid-induced diabetes among people without diabetes subjected to high-dose glucocorticoid, to determine its associated risk factors and to examine the effect of high-dose glucocorticoid on glucose homeostasis. Four databases (Ovid Medline, Scopus, Embase, and PubMed) were searched until August 2017 using the following MeSH terms: ‘glucocorticoid*’, ‘dexamethasone’, ‘diabetes mellitus’ and ‘incidence’. Only studies that included the use of high-dose glucocorticoid (equivalent to 4 mg dexamethasone per day) for at least seven days in their methodology were included. Nine out of 302 identified studies were included in this review. The incidence of glucocorticoid-induced diabetes ranged from 1–50%. Pre-diabetes, age, cumulative dose of glucocorticoid and family history of diabetes were predictors of glucocorticoid-induced diabetes. The use of high-dose glucocorticoid aggravated insulin resistance. Most of the studies were retrospective, and used low-dose glucocorticoid with a short follow-up period. The incidence of glucocorticoid-induced diabetes reported varies widely depending on the type, dose and duration of glucocorticoid, the underlying condition and the presence of established risk factors for diabetes. Further prospective studies testing the effect of glucocorticoid in those without pre-existing risk factors are required to accurately estimate the incidence of glucocorticoid-induced diabetes.

LanguageEnglish
Pages63-67
Number of pages5
JournalPractical Diabetes
Volume35
Issue number2
DOIs
Publication statusPublished - 1 Mar 2018

Fingerprint

Glucocorticoids
Incidence
Dexamethasone
Homeostasis
Glucose
PubMed
Insulin Resistance
Diabetes Mellitus
Retrospective Studies
Databases
Prospective Studies

Keywords

  • diabetes
  • glucocorticoid
  • glucocorticoid-induced diabetes
  • incidence

Cite this

Alabbood, Majid ; Ling, Min ; Ho, Kenneth. / Glucocorticoid-induced diabetes among people without diabetes : a literature review. In: Practical Diabetes. 2018 ; Vol. 35, No. 2. pp. 63-67.
@article{85c55632d58d4e68aa170ef5a5e3a57c,
title = "Glucocorticoid-induced diabetes among people without diabetes: a literature review",
abstract = "The effect of glucocorticoid on glycaemic control in people with diabetes has been studied extensively in the literature. However, data regarding its effect on glucose homeostasis in those without diabetes are sparse. This review aims to investigate the incidence of glucocorticoid-induced diabetes among people without diabetes subjected to high-dose glucocorticoid, to determine its associated risk factors and to examine the effect of high-dose glucocorticoid on glucose homeostasis. Four databases (Ovid Medline, Scopus, Embase, and PubMed) were searched until August 2017 using the following MeSH terms: ‘glucocorticoid*’, ‘dexamethasone’, ‘diabetes mellitus’ and ‘incidence’. Only studies that included the use of high-dose glucocorticoid (equivalent to 4 mg dexamethasone per day) for at least seven days in their methodology were included. Nine out of 302 identified studies were included in this review. The incidence of glucocorticoid-induced diabetes ranged from 1–50{\%}. Pre-diabetes, age, cumulative dose of glucocorticoid and family history of diabetes were predictors of glucocorticoid-induced diabetes. The use of high-dose glucocorticoid aggravated insulin resistance. Most of the studies were retrospective, and used low-dose glucocorticoid with a short follow-up period. The incidence of glucocorticoid-induced diabetes reported varies widely depending on the type, dose and duration of glucocorticoid, the underlying condition and the presence of established risk factors for diabetes. Further prospective studies testing the effect of glucocorticoid in those without pre-existing risk factors are required to accurately estimate the incidence of glucocorticoid-induced diabetes.",
keywords = "diabetes, glucocorticoid, glucocorticoid-induced diabetes, incidence",
author = "Majid Alabbood and Min Ling and Kenneth Ho",
year = "2018",
month = "3",
day = "1",
doi = "10.1002/pdi.2164",
language = "English",
volume = "35",
pages = "63--67",
journal = "Practical Diabetes",
issn = "2047-2897",
publisher = "John Wiley & Sons",
number = "2",

}

Glucocorticoid-induced diabetes among people without diabetes : a literature review. / Alabbood, Majid; Ling, Min; Ho, Kenneth.

In: Practical Diabetes, Vol. 35, No. 2, 01.03.2018, p. 63-67.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Glucocorticoid-induced diabetes among people without diabetes

T2 - Practical Diabetes

AU - Alabbood, Majid

AU - Ling, Min

AU - Ho, Kenneth

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The effect of glucocorticoid on glycaemic control in people with diabetes has been studied extensively in the literature. However, data regarding its effect on glucose homeostasis in those without diabetes are sparse. This review aims to investigate the incidence of glucocorticoid-induced diabetes among people without diabetes subjected to high-dose glucocorticoid, to determine its associated risk factors and to examine the effect of high-dose glucocorticoid on glucose homeostasis. Four databases (Ovid Medline, Scopus, Embase, and PubMed) were searched until August 2017 using the following MeSH terms: ‘glucocorticoid*’, ‘dexamethasone’, ‘diabetes mellitus’ and ‘incidence’. Only studies that included the use of high-dose glucocorticoid (equivalent to 4 mg dexamethasone per day) for at least seven days in their methodology were included. Nine out of 302 identified studies were included in this review. The incidence of glucocorticoid-induced diabetes ranged from 1–50%. Pre-diabetes, age, cumulative dose of glucocorticoid and family history of diabetes were predictors of glucocorticoid-induced diabetes. The use of high-dose glucocorticoid aggravated insulin resistance. Most of the studies were retrospective, and used low-dose glucocorticoid with a short follow-up period. The incidence of glucocorticoid-induced diabetes reported varies widely depending on the type, dose and duration of glucocorticoid, the underlying condition and the presence of established risk factors for diabetes. Further prospective studies testing the effect of glucocorticoid in those without pre-existing risk factors are required to accurately estimate the incidence of glucocorticoid-induced diabetes.

AB - The effect of glucocorticoid on glycaemic control in people with diabetes has been studied extensively in the literature. However, data regarding its effect on glucose homeostasis in those without diabetes are sparse. This review aims to investigate the incidence of glucocorticoid-induced diabetes among people without diabetes subjected to high-dose glucocorticoid, to determine its associated risk factors and to examine the effect of high-dose glucocorticoid on glucose homeostasis. Four databases (Ovid Medline, Scopus, Embase, and PubMed) were searched until August 2017 using the following MeSH terms: ‘glucocorticoid*’, ‘dexamethasone’, ‘diabetes mellitus’ and ‘incidence’. Only studies that included the use of high-dose glucocorticoid (equivalent to 4 mg dexamethasone per day) for at least seven days in their methodology were included. Nine out of 302 identified studies were included in this review. The incidence of glucocorticoid-induced diabetes ranged from 1–50%. Pre-diabetes, age, cumulative dose of glucocorticoid and family history of diabetes were predictors of glucocorticoid-induced diabetes. The use of high-dose glucocorticoid aggravated insulin resistance. Most of the studies were retrospective, and used low-dose glucocorticoid with a short follow-up period. The incidence of glucocorticoid-induced diabetes reported varies widely depending on the type, dose and duration of glucocorticoid, the underlying condition and the presence of established risk factors for diabetes. Further prospective studies testing the effect of glucocorticoid in those without pre-existing risk factors are required to accurately estimate the incidence of glucocorticoid-induced diabetes.

KW - diabetes

KW - glucocorticoid

KW - glucocorticoid-induced diabetes

KW - incidence

UR - http://www.scopus.com/inward/record.url?scp=85045038391&partnerID=8YFLogxK

U2 - 10.1002/pdi.2164

DO - 10.1002/pdi.2164

M3 - Review article

VL - 35

SP - 63

EP - 67

JO - Practical Diabetes

JF - Practical Diabetes

SN - 2047-2897

IS - 2

ER -